New developments in the treatment of chemotherapy-induced neutropenia: focus on balugrastim

Neutropenia and febrile neutropenia are two major complications of chemotherapy. Dose reductions, delays in treatment administration, and the use of granulocyte colony-stimulating factors are equally recommended options to preserve absolute neutrophil count in case of chemotherapy regimens bringing...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Ther Clin Risk Manag
Main Authors: Ghidini, Michele, Hahne, Jens Claus, Trevisani, Francesco, Panni, Stefano, Ratti, Margherita, Toppo, Laura, Tomasello, Gianluca
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2016
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4928625/
https://ncbi.nlm.nih.gov/pubmed/27445479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S80732
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki